
### [NCIT:C8968](http://purl.obolibrary.org/obo/NCIT_C8968)
**Label:** Grade 2 Follicular Lymphoma

**Subclasses:** [NCIT:C7219](http://purl.obolibrary.org/obo/NCIT_C7219) (Grade 2 Cutaneous Follicular Lymphoma), [NCIT:C8130](http://purl.obolibrary.org/obo/NCIT_C8130) (Stage III Grade 2 Follicular Lymphoma), [NCIT:C8072](http://purl.obolibrary.org/obo/NCIT_C8072) (Stage I Grade 2 Follicular Lymphoma), [NCIT:C8117](http://purl.obolibrary.org/obo/NCIT_C8117) (Stage II Grade 2 Follicular Lymphoma), [NCIT:C8156](http://purl.obolibrary.org/obo/NCIT_C8156) (Recurrent Grade 2 Follicular Lymphoma), [NCIT:C8143](http://purl.obolibrary.org/obo/NCIT_C8143) (Stage IV Grade 2 Follicular Lymphoma), 

**Class expressions from DL-Learner:**

- [NCIT:C37188](http://purl.obolibrary.org/obo/NCIT_C37188) (del(6q25-27)) 53.57%
- [NCIT:C36538](http://purl.obolibrary.org/obo/NCIT_C36538) (del(6q23)) 53.57%
- [NCIT:C36449](http://purl.obolibrary.org/obo/NCIT_C36449) (Clonal BCL6 Gene Rearrangement) 53.57%
- [NCIT:C36442](http://purl.obolibrary.org/obo/NCIT_C36442) (Clonal BCL2 Gene Rearrangement) 53.57%
- [NCIT:C36423](http://purl.obolibrary.org/obo/NCIT_C36423) (del(6q21)) 53.57%
- [NCIT:C27752](http://purl.obolibrary.org/obo/NCIT_C27752) (t(2;18)(p12;q21)) 53.57%
- [NCIT:C27748](http://purl.obolibrary.org/obo/NCIT_C27748) (t(9;14)(p13;q32)) 53.57%
- [NCIT:C27213](http://purl.obolibrary.org/obo/NCIT_C27213) (t(14;18)(q32;q21)) 53.57%
- [NCIT:C132020](http://purl.obolibrary.org/obo/NCIT_C132020) (BCL6 Gene Rearrangement) and [NCIT:C36333](http://purl.obolibrary.org/obo/NCIT_C36333) (Clonal Gene Rearrangement) 53.57%
- Thing 53.04%
- [NCIT:C132020](http://purl.obolibrary.org/obo/NCIT_C132020) (BCL6 Gene Rearrangement) 38.93%
- [NCIT:C132020](http://purl.obolibrary.org/obo/NCIT_C132020) (BCL6 Gene Rearrangement) and (not ([NCIT:C40142](http://purl.obolibrary.org/obo/NCIT_C40142) (Uterine Ligament Papillary Cystadenoma Associated with von Hippel-Lindau Disease))) 38.93%
- [NCIT:C132020](http://purl.obolibrary.org/obo/NCIT_C132020) (BCL6 Gene Rearrangement) and (not ([NCIT:C40141](http://purl.obolibrary.org/obo/NCIT_C40141) (Wolffian Adnexal Tumor))) 38.93%
- [NCIT:C132020](http://purl.obolibrary.org/obo/NCIT_C132020) (BCL6 Gene Rearrangement) and (not ([NCIT:C40139](http://purl.obolibrary.org/obo/NCIT_C40139) (Uterine Ligament Clear Cell Adenocarcinoma))) 38.93%
- [NCIT:C132020](http://purl.obolibrary.org/obo/NCIT_C132020) (BCL6 Gene Rearrangement) and (not ([NCIT:C40138](http://purl.obolibrary.org/obo/NCIT_C40138) (Uterine Ligament Endometrioid Adenocarcinoma))) 38.93%


